These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 18567913)
1. Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp. Thamlikitkul V; Tiengrim S J Antimicrob Chemother; 2008 Oct; 62(4):847-8. PubMed ID: 18567913 [No Abstract] [Full Text] [Related]
2. Comment on: Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp. Curcio D; Fernández F J Antimicrob Chemother; 2008 Nov; 62(5):1166-7. PubMed ID: 18689874 [No Abstract] [Full Text] [Related]
3. Susceptibility testing of tigecycline against Acinetobacter spp. by disc diffusion method: withdrawing a therapeutic option by varying the Mueller-Hinton agar? Canigia LF; Bantar C J Antimicrob Chemother; 2008 Dec; 62(6):1463-4. PubMed ID: 18782779 [No Abstract] [Full Text] [Related]
4. Influence of different Mueller-Hinton agars and media age on Etest susceptibility testing of tigecycline. Tan TY; Ng LS; Chen DM Diagn Microbiol Infect Dis; 2010 Sep; 68(1):93-5. PubMed ID: 20727479 [TBL] [Abstract][Full Text] [Related]
5. Impact of test methodology, media type and ion content on the susceptibility of Acinetobacter spp. to tigecycline. Qu J; Zong Z; Yu R; Hu T; Ye H; Lü X J Antimicrob Chemother; 2014 Jun; 69(6):1710-1. PubMed ID: 24481321 [No Abstract] [Full Text] [Related]
6. High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest. Fernández-Mazarrasa C; Mazarrasa O; Calvo J; del Arco A; Martínez-Martínez L J Clin Microbiol; 2009 Mar; 47(3):827-9. PubMed ID: 19144806 [TBL] [Abstract][Full Text] [Related]
7. Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC. Torrico M; González N; Giménez MJ; Alou L; Sevillano D; Navarro D; Díaz-Antolín MP; Larrosa N; Aguilar L; Garcia-Escribano N J Clin Microbiol; 2010 Jun; 48(6):2243-6. PubMed ID: 20351208 [TBL] [Abstract][Full Text] [Related]
8. The susceptibility to tigecycline of Acinetobacter spp. may vary depending on the methodology used. Zárate MS; Serruto G; Smayevsky J Int J Infect Dis; 2010 Sep; 14 Suppl 3():e351-2. PubMed ID: 20031463 [No Abstract] [Full Text] [Related]
9. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. Jones RN; Ferraro MJ; Reller LB; Schreckenberger PC; Swenson JM; Sader HS J Clin Microbiol; 2007 Jan; 45(1):227-30. PubMed ID: 17093026 [TBL] [Abstract][Full Text] [Related]
10. Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view. Curcio D; Fernández F; Jones RN; Ferraro MJ; Reller LB; Schreckenberger PC; Sader HS J Clin Microbiol; 2007 Jun; 45(6):2095; author reply 2095-6. PubMed ID: 17548459 [No Abstract] [Full Text] [Related]
11. Tigecycline susceptibility in multidrug resistant Acinetobacter isolates from Turkey. Yilmaz FF; Taşli H; Gül-Yurtsever S; Büyük A; Hoşgör-Limoncu M Pol J Microbiol; 2013; 62(3):295-8. PubMed ID: 24459835 [TBL] [Abstract][Full Text] [Related]
12. Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective. Curcio D; Fernández F J Antimicrob Chemother; 2007 Aug; 60(2):449-50. PubMed ID: 17561503 [No Abstract] [Full Text] [Related]
13. Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii. Wang P; Bowler SL; Kantz SF; Mettus RT; Guo Y; McElheny CL; Doi Y J Clin Microbiol; 2016 Dec; 54(12):2937-2941. PubMed ID: 27629901 [TBL] [Abstract][Full Text] [Related]
14. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. Hope R; Warner M; Mushtaq S; Ward ME; Parsons T; Livermore DM J Antimicrob Chemother; 2005 Dec; 56(6):1042-6. PubMed ID: 16286361 [TBL] [Abstract][Full Text] [Related]
15. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp. Casal M; Rodríguez F; Johnson B; Garduno E; Tubau F; de Lejarazu RO; Tenorio A; Giménez MJ; Bartolomé R; Garcia-Rey C; Aguilar L; García-Escribano N J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea. Park YK; Choi JY; Song JH; Ko KS Int J Antimicrob Agents; 2009 Mar; 33(3):289-90. PubMed ID: 19091518 [No Abstract] [Full Text] [Related]
17. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates. Ricciardi R; Ricciardi AM; Danzi G Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104 [TBL] [Abstract][Full Text] [Related]
18. Comparing in vitro activity of tigecycline by using the disk diffusion test, the manual microdilution method, and the VITEK 2 automated system. Leal Castro AL; Buitrago Gutierrez G; Ovalle V; Cortes JA; Alvarez CA; Rev Argent Microbiol; 2010; 42(3):208-11. PubMed ID: 21180392 [TBL] [Abstract][Full Text] [Related]
19. Effect of manganese in test media on in vitro susceptibility of Enterobacteriaceae and Acinetobacter baumannii to tigecycline. Veenemans J; Mouton JW; Kluytmans JA; Donnely R; Verhulst C; van Keulen PH J Clin Microbiol; 2012 Sep; 50(9):3077-9. PubMed ID: 22718943 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008. Wang YF; Dowzicky MJ Diagn Microbiol Infect Dis; 2010 Sep; 68(1):73-9. PubMed ID: 20727474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]